Global Generic Injectable Drugs Market Research Report 2026(Status and Outlook)

May 2026 | 144 pages | ID: G2D6887069C4EN
Bosson Research

Abstracts

Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.

The global Generic Injectable Drugs market size was estimated at USD 32770.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 3.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Generic Injectable Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Generic Injectable Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Generic Injectable Drugs market.

Global Generic Injectable Drugs Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Hospira (Pfizer Inc.)
• Fresenius Kabi
• Sandoz (Novartis)
• Hikma Pharmaceuticals PLC
• Dr. Reddy’s Laboratories Ltd
• Grifols
• Nichi-Iko Group (Sagent)
• Teva Pharmaceutical
• Auromedics
• Sanofi
• Gland Pharma
• Endo International PLC

Market Segmentation (by Type)

• Small Molecule
• Large Molecule

Market Segmentation (by Application)

• Oncology
• Anesthesia
• Anti-Infectives
• Parenteral Nutrition
• Cardiovascular Diseases

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Generic Injectable Drugs Market

Overview of the regional outlook of the Generic Injectable Drugs Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Generic Injectable Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Generic Injectable Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Generic Injectable Drugs
1.2 Key Market Segments
  1.2.1 Generic Injectable Drugs Segment by Type
  1.2.2 Generic Injectable Drugs Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GENERIC INJECTABLE DRUGS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Generic Injectable Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Generic Injectable Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GENERIC INJECTABLE DRUGS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Generic Injectable Drugs Product Life Cycle
3.3 Global Generic Injectable Drugs Sales by Manufacturers (2020-2025)
3.4 Global Generic Injectable Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Generic Injectable Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Generic Injectable Drugs Market Competitive Situation and Trends
  3.8.1 Generic Injectable Drugs Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Generic Injectable Drugs Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 GENERIC INJECTABLE DRUGS INDUSTRY CHAIN ANALYSIS

4.1 Generic Injectable Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF GENERIC INJECTABLE DRUGS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Generic Injectable Drugs Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Generic Injectable Drugs Market
5.7 ESG Ratings of Leading Companies

6 GENERIC INJECTABLE DRUGS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Generic Injectable Drugs Sales Market Share by Type (2020-2025)
6.3 Global Generic Injectable Drugs Market Size by Type (2020-2025)
6.4 Global Generic Injectable Drugs Price by Type (2020-2025)

7 GENERIC INJECTABLE DRUGS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Generic Injectable Drugs Market Sales by Application (2020-2025)
7.3 Global Generic Injectable Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Generic Injectable Drugs Sales Growth Rate by Application (2020-2025)

8 GENERIC INJECTABLE DRUGS MARKET SALES BY REGION

8.1 Global Generic Injectable Drugs Sales by Region
  8.1.1 Global Generic Injectable Drugs Sales by Region
  8.1.2 Global Generic Injectable Drugs Sales Market Share by Region
8.2 Global Generic Injectable Drugs Market Size by Region
  8.2.1 Global Generic Injectable Drugs Market Size by Region
  8.2.2 Global Generic Injectable Drugs Market Size by Region
8.3 North America
  8.3.1 North America Generic Injectable Drugs Sales by Country
  8.3.2 North America Generic Injectable Drugs Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Generic Injectable Drugs Sales by Country
  8.4.2 Europe Generic Injectable Drugs Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Generic Injectable Drugs Sales by Region
  8.5.2 Asia Pacific Generic Injectable Drugs Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Generic Injectable Drugs Sales by Country
  8.6.2 South America Generic Injectable Drugs Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Generic Injectable Drugs Sales by Region
  8.7.2 Middle East and Africa Generic Injectable Drugs Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 GENERIC INJECTABLE DRUGS MARKET PRODUCTION BY REGION

9.1 Global Production of Generic Injectable Drugs by Region(2020-2025)
9.2 Global Generic Injectable Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Generic Injectable Drugs Production
  9.4.1 North America Generic Injectable Drugs Production Growth Rate (2020-2025)
  9.4.2 North America Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Generic Injectable Drugs Production
  9.5.1 Europe Generic Injectable Drugs Production Growth Rate (2020-2025)
  9.5.2 Europe Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Generic Injectable Drugs Production (2020-2025)
  9.6.1 Japan Generic Injectable Drugs Production Growth Rate (2020-2025)
  9.6.2 Japan Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Generic Injectable Drugs Production (2020-2025)
  9.7.1 China Generic Injectable Drugs Production Growth Rate (2020-2025)
  9.7.2 China Generic Injectable Drugs Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Hospira (Pfizer Inc.)
  10.1.1 Hospira (Pfizer Inc.) Basic Information
  10.1.2 Hospira (Pfizer Inc.) Generic Injectable Drugs Product Overview
  10.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Product Market Performance
  10.1.4 Hospira (Pfizer Inc.) Business Overview
  10.1.5 Hospira (Pfizer Inc.) SWOT Analysis
  10.1.6 Hospira (Pfizer Inc.) Recent Developments
10.2 Fresenius Kabi
  10.2.1 Fresenius Kabi Basic Information
  10.2.2 Fresenius Kabi Generic Injectable Drugs Product Overview
  10.2.3 Fresenius Kabi Generic Injectable Drugs Product Market Performance
  10.2.4 Fresenius Kabi Business Overview
  10.2.5 Fresenius Kabi SWOT Analysis
  10.2.6 Fresenius Kabi Recent Developments
10.3 Sandoz (Novartis)
  10.3.1 Sandoz (Novartis) Basic Information
  10.3.2 Sandoz (Novartis) Generic Injectable Drugs Product Overview
  10.3.3 Sandoz (Novartis) Generic Injectable Drugs Product Market Performance
  10.3.4 Sandoz (Novartis) Business Overview
  10.3.5 Sandoz (Novartis) SWOT Analysis
  10.3.6 Sandoz (Novartis) Recent Developments
10.4 Hikma Pharmaceuticals PLC
  10.4.1 Hikma Pharmaceuticals PLC Basic Information
  10.4.2 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Overview
  10.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Market Performance
  10.4.4 Hikma Pharmaceuticals PLC Business Overview
  10.4.5 Hikma Pharmaceuticals PLC Recent Developments
10.5 Dr. Reddy’s Laboratories Ltd
  10.5.1 Dr. Reddy’s Laboratories Ltd Basic Information
  10.5.2 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Overview
  10.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Market Performance
  10.5.4 Dr. Reddy’s Laboratories Ltd Business Overview
  10.5.5 Dr. Reddy’s Laboratories Ltd Recent Developments
10.6 Grifols
  10.6.1 Grifols Basic Information
  10.6.2 Grifols Generic Injectable Drugs Product Overview
  10.6.3 Grifols Generic Injectable Drugs Product Market Performance
  10.6.4 Grifols Business Overview
  10.6.5 Grifols Recent Developments
10.7 Nichi-Iko Group (Sagent)
  10.7.1 Nichi-Iko Group (Sagent) Basic Information
  10.7.2 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Overview
  10.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Market Performance
  10.7.4 Nichi-Iko Group (Sagent) Business Overview
  10.7.5 Nichi-Iko Group (Sagent) Recent Developments
10.8 Teva Pharmaceutical
  10.8.1 Teva Pharmaceutical Basic Information
  10.8.2 Teva Pharmaceutical Generic Injectable Drugs Product Overview
  10.8.3 Teva Pharmaceutical Generic Injectable Drugs Product Market Performance
  10.8.4 Teva Pharmaceutical Business Overview
  10.8.5 Teva Pharmaceutical Recent Developments
10.9 Auromedics
  10.9.1 Auromedics Basic Information
  10.9.2 Auromedics Generic Injectable Drugs Product Overview
  10.9.3 Auromedics Generic Injectable Drugs Product Market Performance
  10.9.4 Auromedics Business Overview
  10.9.5 Auromedics Recent Developments
10.10 Sanofi
  10.10.1 Sanofi Basic Information
  10.10.2 Sanofi Generic Injectable Drugs Product Overview
  10.10.3 Sanofi Generic Injectable Drugs Product Market Performance
  10.10.4 Sanofi Business Overview
  10.10.5 Sanofi Recent Developments
10.11 Gland Pharma
  10.11.1 Gland Pharma Basic Information
  10.11.2 Gland Pharma Generic Injectable Drugs Product Overview
  10.11.3 Gland Pharma Generic Injectable Drugs Product Market Performance
  10.11.4 Gland Pharma Business Overview
  10.11.5 Gland Pharma Recent Developments
10.12 Endo International PLC
  10.12.1 Endo International PLC Basic Information
  10.12.2 Endo International PLC Generic Injectable Drugs Product Overview
  10.12.3 Endo International PLC Generic Injectable Drugs Product Market Performance
  10.12.4 Endo International PLC Business Overview
  10.12.5 Endo International PLC Recent Developments

11 GENERIC INJECTABLE DRUGS MARKET FORECAST BY REGION

11.1 Global Generic Injectable Drugs Market Size Forecast
11.2 Global Generic Injectable Drugs Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Generic Injectable Drugs Market Size Forecast by Country
  11.2.3 Asia Pacific Generic Injectable Drugs Market Size Forecast by Region
  11.2.4 South America Generic Injectable Drugs Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Generic Injectable Drugs by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Generic Injectable Drugs Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Generic Injectable Drugs by Type (2026-2035)
  12.1.2 Global Generic Injectable Drugs Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Generic Injectable Drugs by Type (2026-2035)
12.2 Global Generic Injectable Drugs Market Forecast by Application (2026-2035)
  12.2.1 Global Generic Injectable Drugs Sales (K Units) Forecast by Application
  12.2.2 Global Generic Injectable Drugs Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Generic Injectable Drugs Market Size by Type (M USD)
Table 4. Global Generic Injectable Drugs Market Size by Application
Table 5. Generic Injectable Drugs Market Size Comparison by Region (M USD)
Table 6. Global Generic Injectable Drugs Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Generic Injectable Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Generic Injectable Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Generic Injectable Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectable Drugs as of 2025)
Table 11. Global Market Generic Injectable Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Generic Injectable Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Generic Injectable Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Generic Injectable Drugs Sales by Type (K Units)
Table 27. Global Generic Injectable Drugs Market Size by Type (M USD)
Table 28. Global Generic Injectable Drugs Sales (K Units) by Type (2020-2025)
Table 29. Global Generic Injectable Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Generic Injectable Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Generic Injectable Drugs Market Share by Type (2020-2025)
Table 32. Global Generic Injectable Drugs Price (USD/Unit) by Type (2020-2025)
Table 33. Global Generic Injectable Drugs Sales (K Units) by Application
Table 34. Global Generic Injectable Drugs Market Size by Application
Table 35. Global Generic Injectable Drugs Sales by Application (2020-2025) & (K Units)
Table 36. Global Generic Injectable Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Generic Injectable Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Generic Injectable Drugs Market Share by Application (2020-2025)
Table 39. Global Generic Injectable Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Generic Injectable Drugs Sales by Region (2020-2025) & (K Units)
Table 41. Global Generic Injectable Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Generic Injectable Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Generic Injectable Drugs Market Size by Region (2020-2025)
Table 44. North America Generic Injectable Drugs Sales by Country (2020-2025) & (K Units)
Table 45. North America Generic Injectable Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Generic Injectable Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Europe Generic Injectable Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Generic Injectable Drugs Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Generic Injectable Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Generic Injectable Drugs Sales by Country (2020-2025) & (K Units)
Table 51. South America Generic Injectable Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Generic Injectable Drugs Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Generic Injectable Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Generic Injectable Drugs Production (K Units) by Region(2020-2025)
Table 55. Global Generic Injectable Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Generic Injectable Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Generic Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Generic Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Generic Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Generic Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Generic Injectable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Hospira (Pfizer Inc.) Basic Information
Table 63. Hospira (Pfizer Inc.) Generic Injectable Drugs Product Overview
Table 64. Hospira (Pfizer Inc.) Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Hospira (Pfizer Inc.) Business Overview
Table 66. Hospira (Pfizer Inc.) SWOT Analysis
Table 67. Hospira (Pfizer Inc.) Recent Developments
Table 68. Fresenius Kabi Basic Information
Table 69. Fresenius Kabi Generic Injectable Drugs Product Overview
Table 70. Fresenius Kabi Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Fresenius Kabi Business Overview
Table 72. Fresenius Kabi SWOT Analysis
Table 73. Fresenius Kabi Recent Developments
Table 74. Sandoz (Novartis) Basic Information
Table 75. Sandoz (Novartis) Generic Injectable Drugs Product Overview
Table 76. Sandoz (Novartis) Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Sandoz (Novartis) Business Overview
Table 78. Sandoz (Novartis) SWOT Analysis
Table 79. Sandoz (Novartis) Recent Developments
Table 80. Hikma Pharmaceuticals PLC Basic Information
Table 81. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Overview
Table 82. Hikma Pharmaceuticals PLC Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Hikma Pharmaceuticals PLC Business Overview
Table 84. Hikma Pharmaceuticals PLC Recent Developments
Table 85. Dr. Reddy’s Laboratories Ltd Basic Information
Table 86. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Overview
Table 87. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Dr. Reddy’s Laboratories Ltd Business Overview
Table 89. Dr. Reddy’s Laboratories Ltd Recent Developments
Table 90. Grifols Basic Information
Table 91. Grifols Generic Injectable Drugs Product Overview
Table 92. Grifols Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Grifols Business Overview
Table 94. Grifols Recent Developments
Table 95. Nichi-Iko Group (Sagent) Basic Information
Table 96. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Overview
Table 97. Nichi-Iko Group (Sagent) Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Nichi-Iko Group (Sagent) Business Overview
Table 99. Nichi-Iko Group (Sagent) Recent Developments
Table 100. Teva Pharmaceutical Basic Information
Table 101. Teva Pharmaceutical Generic Injectable Drugs Product Overview
Table 102. Teva Pharmaceutical Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Teva Pharmaceutical Business Overview
Table 104. Teva Pharmaceutical Recent Developments
Table 105. Auromedics Basic Information
Table 106. Auromedics Generic Injectable Drugs Product Overview
Table 107. Auromedics Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Auromedics Business Overview
Table 109. Auromedics Recent Developments
Table 110. Sanofi Basic Information
Table 111. Sanofi Generic Injectable Drugs Product Overview
Table 112. Sanofi Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Sanofi Business Overview
Table 114. Sanofi Recent Developments
Table 115. Gland Pharma Basic Information
Table 116. Gland Pharma Generic Injectable Drugs Product Overview
Table 117. Gland Pharma Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Gland Pharma Business Overview
Table 119. Gland Pharma Recent Developments
Table 120. Endo International PLC Basic Information
Table 121. Endo International PLC Generic Injectable Drugs Product Overview
Table 122. Endo International PLC Generic Injectable Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Endo International PLC Business Overview
Table 124. Endo International PLC Recent Developments
Table 125. Global Generic Injectable Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Generic Injectable Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Generic Injectable Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Generic Injectable Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Generic Injectable Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Generic Injectable Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Generic Injectable Drugs Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Generic Injectable Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Generic Injectable Drugs Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Generic Injectable Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Generic Injectable Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Generic Injectable Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Generic Injectable Drugs Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Generic Injectable Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Generic Injectable Drugs Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Generic Injectable Drugs Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Generic Injectable Drugs Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Generic Injectable Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Generic Injectable Drugs Market Size (M USD), 2025-2035
Figure 5. Global Generic Injectable Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Generic Injectable Drugs Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Generic Injectable Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Generic Injectable Drugs Product Life Cycle
Figure 13. Generic Injectable Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Generic Injectable Drugs Revenue Share by Manufacturers in 2025
Figure 15. Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Generic Injectable Drugs Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Generic Injectable Drugs Revenue in 2025
Figure 18. Industry Chain Map of Generic Injectable Drugs
Figure 19. Global Generic Injectable Drugs Market PEST Analysis
Figure 20. Global Generic Injectable Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Generic Injectable Drugs Market Share by Type
Figure 27. Sales Market Share of Generic Injectable Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Generic Injectable Drugs by Type in 2025
Figure 29. Market Share of Generic Injectable Drugs by Type (2020-2025)
Figure 30. Market Share of Generic Injectable Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Generic Injectable Drugs Market Share by Application
Figure 33. Global Generic Injectable Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Generic Injectable Drugs Sales Market Share by Application in 2025
Figure 35. Global Generic Injectable Drugs Market Share by Application (2020-2025)
Figure 36. Global Generic Injectable Drugs Market Share by Application in 2025
Figure 37. Global Generic Injectable Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Generic Injectable Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Generic Injectable Drugs Market Size by Region (2020-2025)
Figure 40. North America Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Generic Injectable Drugs Sales Market Share by Country in 2024
Figure 43. North America Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Generic Injectable Drugs Market Size by Country in 2024
Figure 45. U.S. Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Generic Injectable Drugs Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Generic Injectable Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Generic Injectable Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Generic Injectable Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Generic Injectable Drugs Sales Market Share by Country in 2024
Figure 53. Europe Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Generic Injectable Drugs Market Size by Country in 2024
Figure 55. Germany Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Generic Injectable Drugs Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Generic Injectable Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Generic Injectable Drugs Market Size by Region in 2024
Figure 68. China Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Generic Injectable Drugs Sales and Growth Rate (K Units)
Figure 79. South America Generic Injectable Drugs Sales Market Share by Country in 2024
Figure 80. South America Generic Injectable Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Generic Injectable Drugs Market Size by Country in 2024
Figure 82. Brazil Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Generic Injectable Drugs Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Generic Injectable Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Generic Injectable Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Generic Injectable Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Generic Injectable Drugs Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Generic Injectable Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Generic Injectable Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Generic Injectable Drugs Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Generic Injectable Drugs Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Generic Injectable Drugs Production (K Units) Growth Rate (2020-2025)
Figure 106. China Generic Injectable Drugs Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Generic Injectable Drugs Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Generic Injectable Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Generic Injectable Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Generic Injectable Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Generic Injectable Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Generic Injectable Drugs Market Share Forecast by Application (2026-2035)